Once-daily Roflumilast Cream 0.05% for the Treatment of Atopic Dermatitis in Patients Aged 2–5 Years With Diverse Skin Types: Subgroup Analysis From the Phase 3 INTEGUMENT-PED Trial. J of Skin [Internet]. 2026 Mar. 10 [cited 2026 May 1];10(2):s745. Available from: https://skin.dermsquared.com/skin/article/view/4065